"These medicines have only been studied for short periods," she said, noting uncertainties about long-term safety and possible risks including nutrient deficiencies and changes in mood
Results From July 2020 to December 2021 a total of 265 patients were offered adjuvant pharmacotherapy with semaglutide
If your doctor prescribes it for diabetes only (without weight management), you may not qualify for the self-pay program
Unlike the EMPA REG OUTCOME Study, where the primary benefit was on CV mortality and was observed within 3 months, in both GLP-1 RA studies (LEADER and SUSTAIN-6) the CV benefit was not observed until one year and MI, stroke, and CV death all contributed to the reduction in 3-point MACE
[26] L- [ | ] , L- (L- L- ), , -L- -L-
While tirzepatide does not directly target thyroid function, substantial weight loss may affect thyroid hormone requirements in patients on thyroid replacement therapy, as is generally observed with significant weight changes